Expert international faculty present weekly, concise MedicalMinute updates, host biweekly Question and Answer Webinars, and author a continually updated downloadable slideset including the latest data on COVID-19 epidemiology and clinical management; specific topics include best practices and ongoing research in screening, prevention, diagnosis, disease management, and treatment for diverse patient populations.
Get free and unlimited CME/CE access. Create your account now.
In this presentation, Professor Leo Yee-Sin discusses the incidence of coinfections and superinfections in patients with COVID-19.
In this presentation, Jens D. Lundgren, MD, DMSc, discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19.
In this presentation, Dr. Vikram Mukherjee discusses key recommendations for the management of common comorbidities in the context of COVID-19.
In this presentation, Dr. Adaora Adimora discusses recently published clinical trial and meta-analysis data on the use of corticosteroids to treat COVID-19.
In this presentation, Dr. Wong Chen Seong discusses what is known about COVID-19 symptom persistence and the long-term pulmonary, cardiovascular, and neurologic sequelae in recovered patients
In this presentation, Professor David Heymann provides an overview of the concept of herd immunity and considerations for estimating the herd immunity threshold for SARS-CoV-2.
In this presentation, Professor Jens D. Lundgren discusses the theory behind using convalescent plasma to treat infectious disease and the current evidence and recommendations regarding its use to treat patients with COVID-19.
In this presentation, Professor Sharon Lewin discusses the recent data on the durability of antibody and T cell responses to SARS-CoV-2 and the implications for reinfection.
In this concise presentation, Dr. Vikramjit Mukherjee discusses the presentation and burden of coagulopathy in COVID-19 and the data and recommendations on preventative therapy.
In this presentation, Professor David Heymann provides an update on the development and utility of current diagnostic tests for SARS-CoV-2, with special consideration to how various methods can be used in an epidemiological approach to limit community transmission.
In this presentation, Dr. Sigal Yawetz discusses the current data on COVID-19 risk and disease severity in pregnant women and newborns, treatment options during pregnancy, and best practices for postpartum management of mothers infected with COVID-19.
In this presentation, Professor David Heymann discusses the current data on SARS-CoV-2 transmission, including mechanisms, timing, and protective strategies.
In this presentation, Professor Sharon Lewin discusses the rapid development of SARS-CoV-2 vaccines and the emerging safety and immunogenicity data from clinical trials investigating several vaccine candidates.
In this concise presentation, Dr. Vikramjit Mukherjee discusses presentation and disease severity of COVID-19 in children and the diagnosis, incidence, and management of multisystem inflammatory syndrome in children.
In this presentation, Professor Jens D. Lundgren discusses the immune response to SARS-CoV-2 in relation to disease presentation and severity in immunocompromised patients, including solid organ transplant patients, patients on immunomodulatory therapies, and patients with HIV.
In this concise presentation, Professor Jens D. Lundgren discusses the RECOVERY trial data and the updated guidance on administering dexamethasone to treat COVID-19.
In this presentation, Dr. Vikramjit Mukherjee discusses medical management for severe to critical COVID-19, including the latest guidance and information on evolving treatment options.
In this presentation, Dr. Adaora Adimora discusses the disproportionate number of COVID-19 cases and deaths among Black and Latinx populations and factors that influence these disparities.
In this presentation, Dr. Adaora Adimora discusses medical management for mild to moderate COVID-19, including current treatment recommendations and data on investigational therapies.
In this presentation, Professor Leo Yee-Sin discusses COVID-19 clinical manifestation, including the current data on common symptoms, risk factors for severe disease, and disease course.
In this presentation, Professor Jens D. Lundgren discusses COVID-19 diagnosis, including clinical suspicion of infection and temporal considerations for detecting SARS-CoV-2 using current methods.
In this presentation, Professor Sharon Lewin discusses the kinetics of the antibody response following SARS-CoV-2 infection, current tests for antibody detection, and the use of serology assays in COVID-19 diagnosis and epidemiological studies
In this concise presentation, Dr. Vikramjit Mukherjee discusses the indications, dosing guidelines, and special considerations outlined in the FDA emergency use authorization of remdesivir for treatment of COVID-19.